The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular Diseases
Abstract
The natriuretic peptide system includes three known peptides: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). They contribute to the regulation of cardiovascular homeostasis through diuretic, natriuretic, and vasodilatory properties. Among them, ANP has received particular attention because of its effects on blood pressure regulation and cardiac function. Although the potential for its therapeutic application in the treatment of hypertension and heart failure has been evaluated in several experimental and clinical investigations, no pharmacological approach directly targeted at modulation of ANP levels has ever reached the stage of being incorporated into clinical practice. Recently, ANP has also received attention as being a possible cardiovascular risk factor, particularly in the context of hypertension, stroke, obesity, and metabolic syndrome. Abnormalities in either peptide levels or peptide structure are thought to underlie its implied role in mediating cardiovascular diseases. Meanwhile, BNP has emerged as a relevant marker of left ventricular (LV) dysfunction and as a useful predictor of future outcome in patients with heart failure. This review deals with the major relevant findings related to the cardiovascular and metabolic effects of natriuretic peptides, to their potential therapeutic use, and to their role in mediating cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Obesity on Plasma Natriuretic Peptide Levels
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022
Bergandi, L., Silvagno, F., Russo, I., Riganti, C., Anfossi, G., Aldieri, E., Ghigo, D., Trovati, M., & Bosia, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000107028.20478.8e · Cited by 93
Cited by
Pilz, S., März, W., Wellnitz, B., Seelhorst, U., Fahrleitner-Pammer, A., Dimai, H. P., Boehm, B. O., & Dobnig, H. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0784 · Cited by 607
Gu, J., Noe, A., Chandra, P., Al‐Fayoumi, S., Ligueros‐Saylan, M., Sarangapani, R., Maahs, S., Ksander, G., Rigel, D. F., Jeng, A. Y., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009343932 · Cited by 505
Natriuretic peptides in cardiovascular diseases: current use and perspectives
Volpe, M., Rubattu, S., & Burnett, J. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht466 · Cited by 277
Self-citationScallan, J. P., Davis, M. J., & Huxley, V. H. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.260042 · Cited by 49
Ghanim, H., Monte, S., Caruana, J., Green, K., Abuaysheh, S., & Dandona, P. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13320 · Cited by 36
Metadata
- Authors
- Rubattu, S., Sciarretta, S., Valenti, V., Stanzione, R., & Volpe, M.
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-01
- Volume
- 21
- Issue
- 7
- Pages
- 733-741
- ISSN
- 0895-7061 (ISSN-L)
- 1941-7225
- OpenAlex
- W2124528949
- Cited by
- 195
- References
- 2
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular Diseases. https://app.cochat.ai/papers/10.1038/ajh.2008.174
- The paper
- Rubattu, S., Sciarretta, S., Valenti, V., Stanzione, R., & Volpe, M. (2008). Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular Diseases. American Journal of Hypertension. https://doi.org/10.1038/ajh.2008.174
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.